Contrast media injectors are devices employed for injecting contrast media into the body to improve the visibility of tissues for medical imaging procedures. Currently, market players are engaged in developing contrast injectors with enhanced capabilities, such as improved patient safety, patient imaging data integration and higher specificity.
The contrast media injectors market is projected to reach $2.4 billion by 2024, according to a MarketsandMarkets report.
“The major factors driving the growth of the contrast media injectors industry include a large number of approvals for contrast agents, increasing investments, funds, and grants by government organizations, and rising demand for early diagnosis and widening the scope of clinical applications. However, the reluctance to adopt new technologies, and a shortage of trained professionals, will challenge market growth,” according to MarketsandMarkets.
The contrast media injectors market studied is anticipated to grow with a CAGR of 5.5%, during the forecast period (2019-2024), according to a Mordor Intelligence report.
The major factors attributing to the growth of the contrast media injectors market are increasing demand for minimally invasive surgeries. Even the technological advancements are helping the market grow, along with the increasing number of regulatory approvals, according to Mordor Intelliegence.
“For instance, there have been several advancements in contrast media injector technology to reduce contrast media waste and to automate data collection regarding the dose a patient receives. Such as the automated injector systems precisely collects the amount of contrast media used, and vendors have started offering personalized doses for the patients using the information pulled from EMR or PACS,” according to the report. “One such advancement in reducing contrast media waste is syringeless injectors. According to a study published online in, the Journal of Medical Devices: Evidence and Research in November 2013, syringeless injectors provide cost savings of about $8 per patient. Most of the companies are developing innovative products to reduce contrast media waste and gain a competitive advantage.”
“Bracco has developed smart syringeless injectors, which are able to use every drop of contrast loaded into the system for maximum economy,” the report adds. “The smart injectors record the amount injected and imaging protocol used and send the information to the PACS. These constant technological advancements in the contrast media injector technology are expected to boost the contrast media injector market during the forecast period.”
The CT injector systems segment of the market is expected to grow.
“CT injectors are expected to grow positively as the usage of the CT systems has been increasing from the past few years, and these CT systems use a dual-head injector, with two syringes for initial and follow-up contrast doses, during imaging,” according to the report. “There has been constant R&D activity by major academic centers and pharmaceutical companies to develop protocols, which helps CT users with the advanced capabilities of newer imaging systems. And the injectors such as Covidien’s Optivantage dual-head contrast injector for CT, launched in 2012, use a radio-frequency identification (RFID)-enabled system. The integration of IT and contrast media dose management are prospective growth factors for the forecast period.”
Manufacturers of CT and automated contrast injectors are partnering to better integrate their systems.
“This includes contrast dose tracking. Mallinckrodt has launched an OptiSync data management system, which is designed to collect and analyze radiology data when a patient undergoes a contrast-media-enhanced CT imaging procedure. All these factors are expected to help the market to grow positively over the forecast period,” Mordor Intelligence reports.
North America is expected to dominate the overall market.
“This is due to factors such as increasing preference for minimally invasive procedures and increasing prevalence of chronic diseases owing to changing lifestyles. Furthermore, technological advancements in contrast media injectors devices and increasing expenditure by key players, along with rising regulatory approvals, are also boosting the growth of the contrast media injectors market in North America. In North America region, the United States holds the largest market share,” the report states.
